Advances in Hematological Malignancies
Recent decades have witnessed remarkable strides in the domain of hematological malignancies. Novel therapies such as targeted agents, immunotherapies, and gene editing are revolutionizing the outlook for patients with blood cancers. Ongoing investigations continue to explore these innovative strategies, offering promise for more curative treatment